# Robin Healthcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/robin-healthcare

- Industry: Healthcare IT
- Headquarters: Berkeley, US
- Website: www.robinhealthcare.com
- Total disclosed funding: $65M
- Latest round: Series B (Dec 8, 2021)
- Investors on record: 6

## About

Robin Healthcare specializes in healthcare documentation and data capture solutions, leveraging artificial intelligence to optimize clinical workflows and improve patient care for healthcare providers.Founded in 2017 and headquartered in Berkeley, US, Robin Healthcare focuses on enhancing healthcare documentation. The company has completed 4 deals, with its most recent funding round being a Venture Debt round on October 24, 2022, raising USD 7.00 mn from Horizon Technology Finance. To date, the total amount raised by the company is USD 50.00 mn. Noah Auerhahn serves as both the CEO and founder, with a background in prior entrepreneurial ventures.Robin Healthcare's core offerings focus on advanced healthcare documentation and data capture technologies aimed at enhancing clinical workflows within medical practices. The company's flagship product utilizes artificial intelligence to assist healthcare professionals in streamlining their documentation processes, thereby allowing them to prioritize patient care over administrative burdens. These solutions target pain points such as time-consuming note-taking and data entry that often detract from patient interactions. Robin Healthcare serves a diverse clientele that includes hospitals, outpatient clinics, and private practices across various specialties, ultimately benefiting healthcare providers and their patients alike. Geographically, their products are available in markets such as the United States, Canada, and select regions in Europe, reflecting a commitment to improving healthcare delivery across borders.Robin Healthcare's revenue generation model is founded on a subscription-based structure, where healthcare providers pay for access to their technology solutions. Clients engage in annual or monthly subscription plans that offer tiered services based on the needs of the practice, which may include varying levels of AI support and additional features tailored for specific healthcare settings. These transactions facilitate direct business-to-business relationships, enabling seamless integration of their systems into existing clinical workflows. By offering a range of subscription plans, Robin Healthcare ensures that its products are accessible to a wide array of medical practices, from small clinics to large healthcare systems, allowing for scalable revenue growth tied to client adoption and retention of their innovative services.In October 2022, Robin Healthcare raised USD 7.00 mn in a Venture Debt funding round, which is part of a larger USD 17.00 mn venture debt round. The company plans to use this funding for general corporate and working capital. Future initiatives include the design and launch of new products tailored to enhance existing services, with specific release dates to be announced. Additionally, Robin Healthcare aims to expand its presence in new markets, targeting regions in Europe and Canada for growth by 2024.

## Funding rounds

- Series B, Dec 8, 2021, $50M — Norwest Venture Partners, Scale Venture Partners, Khosla Ventures, IA Ventures, Social Leverage Capital, Meridian Street Capital
- Series A, Sep 18, 2019, $12M — Norwest Venture Partners
- Seed, May 30, 2018, $3.5M — IA Ventures, Social Leverage Capital, Meridian Street Capital

## Investors

- IA Ventures (https://capitalatlas.ai/funds/ia-ventures) — Seed, Series B
- Social Leverage Capital (https://capitalatlas.ai/funds/social-leverage-capital) — Seed, Series B
- Meridian Street Capital (https://capitalatlas.ai/funds/meridian-street-capital) — Seed, Series B
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series A, Series B
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series B
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series B